RE: ........askretka
Recall as well Al that this last Q's MD&A https://www.transitiontherapeutics.com/ir/financial_reports/2q2008.pdf included the statement........"Transition and its partner Elan are considering initiating clinical trials for other amyloid beta related indications including Pre-Alzheimer’s disease."
Now Dr. Cruz did elaborate during the Q2 CC on the AZD-103 Phasell in Pre-Alzheimers being planned with ELAN but from reading the Q2 MD&A as shown above it seems they may also be considering other Indications. Is Glaucoma one of them???
GLA